|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US6117643A
(en)
*
|
1997-11-25 |
2000-09-12 |
Ut Battelle, Llc |
Bioluminescent bioreporter integrated circuit
|
|
CA2358296A1
(en)
*
|
1999-01-05 |
2000-07-13 |
Anthony P. Adamis |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
ES2240180T3
(es)
|
1999-10-21 |
2005-10-16 |
Alcon Inc. |
Administracion sub-tenon de medicamentos.
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
JP4837861B2
(ja)
*
|
1999-10-21 |
2011-12-14 |
アルコン，インコーポレイティド |
ドラッグデリバリ製剤
|
|
US6331313B1
(en)
*
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
US6726918B1
(en)
*
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
|
US20040170955A1
(en)
*
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
|
US7452964B2
(en)
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
|
US20050074747A1
(en)
*
|
2000-09-08 |
2005-04-07 |
Wadih Arap |
Biopanning and rapid analysis of selective interactive ligands (brasil)
|
|
US7420030B2
(en)
*
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
|
WO2002036175A2
(en)
*
|
2000-11-03 |
2002-05-10 |
Control Delivery Systems |
Sustained release device for treating conditions of the joint
|
|
ES2250504T3
(es)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
|
CA2434156A1
(en)
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
|
EP1847255A3
(en)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
|
WO2002053129A1
(en)
*
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
|
JP2004522730A
(ja)
*
|
2001-01-03 |
2004-07-29 |
ボシュ・アンド・ロム・インコーポレイテッド |
コーティングされた薬剤コアを備えた徐放薬剤送達装置
|
|
EP1365738A2
(en)
*
|
2001-01-26 |
2003-12-03 |
Bausch & Lomb Incorporated |
Improved process for the production of sustained release drug delivery devices
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US8541021B2
(en)
*
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
|
JP4116447B2
(ja)
|
2001-05-01 |
2008-07-09 |
エイ．ブイ．トップチーブ インスティテュート オブ ペトロケミカル シンセシス |
ヒドロゲル組成物
|
|
RU2286801C2
(ru)
*
|
2001-05-01 |
2006-11-10 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Двухфазные биоадгезионные композиции, абсорбирующие воду
|
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
|
JP2004536631A
(ja)
|
2001-05-03 |
2004-12-09 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
移植可能な薬物送達デバイスおよびその使用
|
|
ATE506929T1
(de)
*
|
2001-06-12 |
2011-05-15 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
EP1418932A4
(en)
*
|
2001-07-18 |
2006-03-15 |
Univ Texas |
ANTIANGIOGENIC CONDITION IN MICE AND PEOPLE WITH RETINAL PHOTOREEPEPTOR DEGENERATION
|
|
WO2003009774A2
(en)
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
PL204645B1
(pl)
*
|
2001-07-23 |
2010-01-29 |
Alcon |
Okulistyczne urządzenie do podawania leków
|
|
ES2393101T3
(es)
|
2001-08-29 |
2012-12-18 |
Ricardo A. P. De Carvalho |
Sistema implantable y sellable para la administración unidireccional de agentes terapéuticos a tejidos diana
|
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
|
US20040048243A1
(en)
*
|
2001-09-07 |
2004-03-11 |
Wadih Arap |
Methods and compositions for in vitro targeting
|
|
US8507445B2
(en)
*
|
2001-09-07 |
2013-08-13 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US7671010B2
(en)
*
|
2002-08-30 |
2010-03-02 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
|
ES2277084T3
(es)
*
|
2002-01-31 |
2007-07-01 |
Disease Control Textiles Sa |
Difusor de insecticida laminado.
|
|
AU2003216379A1
(en)
*
|
2002-02-22 |
2003-09-09 |
Control Delivery Systems, Inc. |
Method for treating otic disorders
|
|
US7621907B2
(en)
*
|
2002-03-11 |
2009-11-24 |
Alcon, Inc. |
Implantable drug delivery system
|
|
EP1495120B1
(en)
*
|
2002-04-18 |
2012-10-10 |
Acuity Pharmaceuticals, Inc |
Means and methods for the specific modulation of target genes in the eye
|
|
AU2003217531A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
AU2003234294A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Control Delivery Systems, Inc. |
Device and method for treating conditions of a joint
|
|
CN1658836A
(zh)
*
|
2002-05-07 |
2005-08-24 |
控制传输系统公司 |
形成药物传递装置的方法
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
CN100469776C
(zh)
|
2002-05-17 |
2009-03-18 |
奥特拉控股公司 |
白内障和其它眼病发展的改善
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
JP4463681B2
(ja)
|
2002-07-15 |
2010-05-19 |
アルコン，インコーポレイテッド |
眼内使用のための非ポリマー親油性薬学的インプラント組成物
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
US20040221855A1
(en)
*
|
2002-10-17 |
2004-11-11 |
Paul Ashton |
Methods for monitoring treatment of disease
|
|
WO2004043435A2
(en)
*
|
2002-11-13 |
2004-05-27 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
CA2729967C
(en)
*
|
2002-12-13 |
2018-01-16 |
Schering-Plough Healthcare Products, Inc. |
Use of a transdermal or transmucosal ingredient delivery device
|
|
EP1572216A1
(en)
*
|
2002-12-20 |
2005-09-14 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
EP1604010B1
(en)
|
2003-01-16 |
2010-08-11 |
The Trustees of The University of Pennsylvania |
COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ICAM-1
|
|
CN1741792A
(zh)
*
|
2003-01-24 |
2006-03-01 |
控制递送系统有限公司 |
经眼部递送肾上腺素能剂的持续释放系统和方法
|
|
AR042917A1
(es)
*
|
2003-01-24 |
2005-07-06 |
Control Delivery Sys Inc |
Dispositivo de liberacion sostenida para la administracion ocular de agentes adrenergicos y uso de agentes adrenergicos para su preparacion
|
|
DE602004024642D1
(de)
*
|
2003-01-24 |
2010-01-28 |
Psivida Inc |
Vorrichtung zur verlängerten freisetzung und methode zur okularen verabreichung von carboanhydrase inhibitoren
|
|
WO2004066939A2
(en)
*
|
2003-01-27 |
2004-08-12 |
Sarnoff Corporation |
Controlled-release drug delivery system
|
|
US20060167435A1
(en)
*
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US8029477B2
(en)
|
2003-12-19 |
2011-10-04 |
Ethicon Endo-Surgery, Inc. |
Applier with safety for implantable medical device
|
|
US8715243B2
(en)
*
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
|
US7862546B2
(en)
*
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
|
US7561916B2
(en)
|
2005-06-24 |
2009-07-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with indicator
|
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
|
PL1641914T3
(pl)
|
2003-06-27 |
2017-01-31 |
DePuy Synthes Products, Inc. |
Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek
|
|
US8790637B2
(en)
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
|
US7875272B2
(en)
|
2003-06-27 |
2011-01-25 |
Ethicon, Incorporated |
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
|
|
US8491883B2
(en)
*
|
2003-06-27 |
2013-07-23 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
|
|
US8518390B2
(en)
|
2003-06-27 |
2013-08-27 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
|
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
|
WO2005007020A2
(en)
*
|
2003-07-03 |
2005-01-27 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
|
AU2004258857A1
(en)
*
|
2003-07-10 |
2005-02-03 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
CN1882338A
(zh)
*
|
2003-09-18 |
2006-12-20 |
马库赛特公司 |
经巩膜递送
|
|
NZ575950A
(en)
*
|
2003-11-13 |
2010-06-25 |
Psivida Inc |
Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
|
|
AU2004293105B2
(en)
*
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US8162897B2
(en)
*
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
|
US20050148948A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Caputa Steven G. |
Sutureless ophthalmic drug delivery system and method
|
|
DE10360185A1
(de)
*
|
2003-12-20 |
2005-08-04 |
Max Wyssmann |
Vorrichtung zur gezielten, steuerbaren Abgabe oder zum Ansaugen einer Flüssigkeit oder einer viskosen Masse
|
|
US20050158365A1
(en)
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
|
US20050137538A1
(en)
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
|
US7976858B2
(en)
|
2004-01-13 |
2011-07-12 |
The Hospital For Special Surgery |
Drug delivery to a joint
|
|
AU2005209242A1
(en)
*
|
2004-01-26 |
2005-08-11 |
Psivida Inc. |
Controlled and sustained delivery of nucleic acid-based therapeutic agents
|
|
EP1713450B1
(en)
|
2004-01-30 |
2021-10-06 |
Corium, Inc. |
Rapidly dissolving film for delivery of an active agent
|
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
WO2005115375A1
(en)
*
|
2004-05-25 |
2005-12-08 |
Othera Pharmaceuticals, Inc. |
Oculoselective drugs and prodrugs
|
|
EP2803357B1
(en)
|
2004-06-25 |
2020-11-18 |
The Johns-Hopkins University |
Angiogenesis inhibitors
|
|
EP2377569A1
(en)
|
2004-07-02 |
2011-10-19 |
QLT Plug Delivery, Inc. |
Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
|
|
WO2006014484A2
(en)
*
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
|
JP5270158B2
(ja)
*
|
2004-08-05 |
2013-08-21 |
コリウム インターナショナル， インコーポレイテッド |
粘着性組成物
|
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
|
US20060067979A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
|
US20060067980A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
|
WO2006101548A2
(en)
*
|
2004-12-21 |
2006-09-28 |
Ethicon, Inc. |
Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
|
|
WO2006083394A2
(en)
*
|
2004-12-21 |
2006-08-10 |
Ethicon, Inc. |
Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
|
|
US20060153815A1
(en)
*
|
2004-12-21 |
2006-07-13 |
Agnieszka Seyda |
Tissue engineering devices for the repair and regeneration of tissue
|
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
WO2006068898A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
|
JP5425399B2
(ja)
|
2004-12-23 |
2014-02-26 |
エシコン・インコーポレイテッド |
産褥由来細胞を用いたパーキンソン病および関連の障害の治療
|
|
ES2621847T3
(es)
|
2004-12-23 |
2017-07-05 |
DePuy Synthes Products, Inc. |
Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
WO2006086750A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Liquid formulations for treatment of diseases or conditions
|
|
CA2602525A1
(en)
*
|
2005-03-21 |
2006-09-28 |
Macusight, Inc. |
Drug delivery systems for treatment of diseases or conditions
|
|
WO2006110487A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Surmodics, Inc. |
Sustained release implants for subretinal delivery
|
|
US20080312283A1
(en)
*
|
2005-05-26 |
2008-12-18 |
Othera Pharmaceuticals, Inc. |
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
|
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
|
US7651483B2
(en)
*
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
EP2374451A3
(en)
|
2005-07-27 |
2012-01-25 |
University of Florida Research Foundation, Inc. |
Histone deacetylase inhibitors (HDAC) that correct protein misfolding and uses thereof
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
US20080293691A1
(en)
|
2005-11-29 |
2008-11-27 |
Smithkline Beecham Corporation |
Treatment Method
|
|
ES2642844T3
(es)
*
|
2005-12-16 |
2017-11-20 |
DePuy Synthes Products, Inc. |
Composiciones y métodos para inhibir una respuesta inmune adversa en el trasplante de histocompatibilidad que no coinciden
|
|
EP1979050B1
(en)
*
|
2005-12-28 |
2017-04-19 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using postpartum-derived cells
|
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
CA2635797C
(en)
|
2006-02-09 |
2015-03-31 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
WO2007112052A2
(en)
|
2006-03-23 |
2007-10-04 |
Macusight, Inc. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
ES2640458T3
(es)
|
2006-03-31 |
2017-11-03 |
Mati Therapeutics Inc. |
Implantes del sistema de drenaje nasolagrimal para terapia medicamentosa
|
|
US20090130212A1
(en)
*
|
2006-05-15 |
2009-05-21 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
|
WO2007146953A2
(en)
*
|
2006-06-12 |
2007-12-21 |
Exegenics, Inc., D/B/A Opko Health, Inc. |
Compositions and methods for sirna inhibition of angiogenesis
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
ES2403512T3
(es)
*
|
2006-08-07 |
2013-05-20 |
Bausch & Lomb Incorporated |
Composiciones y métodos para tratar, controlar, reducir, o mejorar infecciones y sus secuelas
|
|
WO2008027796A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Bausch & Lomb Incorporated |
Compositions and methods for treating or preventing glaucoma or progression thereof
|
|
US7872118B2
(en)
*
|
2006-09-08 |
2011-01-18 |
Opko Ophthalmics, Llc |
siRNA and methods of manufacture
|
|
ATE506061T1
(de)
*
|
2006-09-11 |
2011-05-15 |
Bausch & Lomb |
Zusammensetzungen und verfahren zur behandlung, kontrolle, verminderung, verbesserung bzw. prävention von allergien
|
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
WO2008103613A2
(en)
|
2007-02-22 |
2008-08-28 |
Othera Holding, Inc. |
Hydroxylamine compounds and methods of their use
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
|
US20090087443A1
(en)
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
|
CA2701435C
(en)
*
|
2007-10-05 |
2017-06-20 |
Ethicon, Inc. |
Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
BRPI0910460A2
(pt)
|
2008-04-17 |
2018-02-14 |
Allergan Inc |
dispositivo de porta de acesso implantável e sistema de fixação
|
|
US9023063B2
(en)
|
2008-04-17 |
2015-05-05 |
Apollo Endosurgery, Inc. |
Implantable access port device having a safety cap
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
WO2010065834A1
(en)
|
2008-12-04 |
2010-06-10 |
Opko Ophthalmics, Llc |
Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
|
|
US20100143437A1
(en)
*
|
2008-12-09 |
2010-06-10 |
Morris Edward J |
Implantable analgesic
|
|
AU2009327382B2
(en)
*
|
2008-12-19 |
2014-07-17 |
DePuy Synthes Products, LLC |
Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
|
|
AU2009327383B2
(en)
*
|
2008-12-19 |
2014-08-28 |
DePuy Synthes Products, LLC |
Regeneration and repair of neural tissue following injury
|
|
CA2747794C
(en)
|
2008-12-19 |
2018-10-30 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of lung and pulmonary diseases and disorders
|
|
US10179900B2
(en)
*
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
|
AU2010204986B2
(en)
*
|
2009-01-14 |
2016-06-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CA3045436C
(en)
|
2009-01-29 |
2025-10-07 |
Forsight Vision4, Inc. |
ADMINISTRATION OF A MEDICATION IN THE POSTERIOR SEGMENT
|
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
SG174551A1
(en)
|
2009-03-26 |
2011-10-28 |
Ethicon Inc |
Human umbilical cord tissue cells as therapy for alzheimer' s disease
|
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
|
US8372036B2
(en)
*
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
CA2762536C
(en)
|
2009-05-18 |
2019-05-21 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
CA2764063C
(en)
|
2009-06-03 |
2019-05-14 |
Forsight Labs, Llc |
Anterior segment drug delivery
|
|
IN2012DN00352A
(uk)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8506532B2
(en)
|
2009-08-26 |
2013-08-13 |
Allergan, Inc. |
System including access port and applicator tool
|
|
US8708979B2
(en)
|
2009-08-26 |
2014-04-29 |
Apollo Endosurgery, Inc. |
Implantable coupling device
|
|
US8715158B2
(en)
|
2009-08-26 |
2014-05-06 |
Apollo Endosurgery, Inc. |
Implantable bottom exit port
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
JP2013512677A
(ja)
*
|
2009-12-04 |
2013-04-18 |
オプコ オプサルミクス、エルエルシー |
Ｖｅｇｆの阻害のための組成物および方法
|
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
CA2785468A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
|
US20110189174A1
(en)
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
US8882728B2
(en)
|
2010-02-10 |
2014-11-11 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US20110270025A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Remotely powered remotely adjustable gastric band system
|
|
US8992415B2
(en)
|
2010-04-30 |
2015-03-31 |
Apollo Endosurgery, Inc. |
Implantable device to protect tubing from puncture
|
|
US20110270021A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Electronically enhanced access port for a fluid filled implant
|
|
WO2011146483A1
(en)
*
|
2010-05-17 |
2011-11-24 |
Aerie Pharmaceuticals, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
|
EP2585057B1
(en)
|
2010-06-25 |
2017-08-23 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Methods of treatment using sterculic acid
|
|
US9492315B2
(en)
|
2010-08-05 |
2016-11-15 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
|
US20120041258A1
(en)
|
2010-08-16 |
2012-02-16 |
Allergan, Inc. |
Implantable access port system
|
|
US20120065460A1
(en)
|
2010-09-14 |
2012-03-15 |
Greg Nitka |
Implantable access port system
|
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
WO2012080833A2
(en)
|
2010-12-13 |
2012-06-21 |
Purdue Pharma L.P. |
Controlled release dosage forms
|
|
US8821373B2
(en)
|
2011-05-10 |
2014-09-02 |
Apollo Endosurgery, Inc. |
Directionless (orientation independent) needle injection port
|
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP4249059B1
(en)
|
2011-06-28 |
2025-07-30 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
|
EP2739252A4
(en)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
SMALL MOLECULE ADMINISTRATION USING AN IMPLANTABLE THERAPEUTIC DEVICE
|
|
US8801597B2
(en)
|
2011-08-25 |
2014-08-12 |
Apollo Endosurgery, Inc. |
Implantable access port with mesh attachment rivets
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
CN103889401B
(zh)
|
2011-08-29 |
2017-10-13 |
Qlt公司 |
持续释放递送活性剂以治疗青光眼和高眼压
|
|
ES2912370T3
(es)
|
2011-09-14 |
2022-05-25 |
Forsight Vision5 Inc |
Aparato para inserción ocular
|
|
EP3903733B1
(en)
|
2011-09-16 |
2025-08-27 |
ForSight Vision4, Inc. |
Fluid exchange apparatus
|
|
US9499464B2
(en)
|
2011-10-19 |
2016-11-22 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US9199069B2
(en)
|
2011-10-20 |
2015-12-01 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US8858421B2
(en)
|
2011-11-15 |
2014-10-14 |
Apollo Endosurgery, Inc. |
Interior needle stick guard stems for tubes
|
|
US9089395B2
(en)
|
2011-11-16 |
2015-07-28 |
Appolo Endosurgery, Inc. |
Pre-loaded septum for use with an access port
|
|
EP2785346A4
(en)
|
2011-11-30 |
2015-04-29 |
Bikam Pharmaceuticals Inc |
OPSINBINDING LIGANDS, COMPOSITIONS THEREOF, AND METHOD OF USE THEREOF
|
|
CA2862746A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
CN104837987B
(zh)
|
2011-12-23 |
2018-10-02 |
德普伊新特斯产品公司 |
人脐带组织来源的细胞的检测
|
|
US10080648B2
(en)
|
2012-01-24 |
2018-09-25 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US9364316B1
(en)
*
|
2012-01-24 |
2016-06-14 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US10028824B2
(en)
|
2012-01-24 |
2018-07-24 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
CA2861865C
(en)
|
2012-01-24 |
2020-12-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Modular intraocular lens designs and methods
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
KR101969594B1
(ko)
*
|
2012-05-11 |
2019-04-16 |
서강대학교산학협력단 |
안내 약물 전달 임플란트
|
|
JP6298068B2
(ja)
|
2012-10-26 |
2018-03-20 |
フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． |
眼に対する薬物徐放用眼科システム
|
|
US10981961B2
(en)
|
2013-03-11 |
2021-04-20 |
University Of Florida Research Foundation, Incorporated |
Delivery of card protein as therapy for occular inflammation
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
US9526654B2
(en)
|
2013-03-28 |
2016-12-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
JP6340673B2
(ja)
|
2013-05-02 |
2018-06-13 |
レティナ ファウンデーション オブ ザ サウスウエストＲｅｔｉｎａ Ｆｏｕｎｄａｔｉｏｎ Ｏｆ Ｔｈｅ Ｓｏｕｔｈｗｅｓｔ |
二層型眼用インプラント
|
|
ES2740352T3
(es)
*
|
2013-11-14 |
2020-02-05 |
Eyed Pharma |
Dispositivo ocular
|
|
EP3068371A1
(en)
*
|
2013-11-15 |
2016-09-21 |
Glaukos Corporation |
Ocular implants configured to store and release stable drug formulations
|
|
CA3184269A1
(en)
|
2014-02-18 |
2015-08-27 |
Alcon, Inc. |
Modular intraocular lens designs, tools and methods
|
|
EP3677229A1
(en)
|
2014-05-29 |
2020-07-08 |
Glaukos Corporation |
Implants with controlled drug delivery features
|
|
US9580896B2
(en)
|
2014-07-05 |
2017-02-28 |
John David Hopkins |
Apparatus and method for prolonged active agent in aqueous systems
|
|
MX384889B
(es)
|
2014-07-15 |
2025-03-14 |
Forsight Vision4 Inc |
Dispositivo y metodo de entrega de implante ocular.
|
|
RU2017105844A
(ru)
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
AU2015346450B2
(en)
|
2014-11-10 |
2020-01-30 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
|
CA3239477A1
(en)
|
2015-01-30 |
2016-08-04 |
Alcon, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
US11458041B2
(en)
|
2015-10-08 |
2022-10-04 |
Ocular Therapeutix, Inc. |
Punctal plug and bioadhesives
|
|
CN113730030B
(zh)
|
2015-11-04 |
2024-08-16 |
克拉维斯塔医疗有限公司 |
模块化人工晶状体设计、工具和方法
|
|
CN113069681B
(zh)
|
2015-11-20 |
2022-12-23 |
弗赛特影像4股份有限公司 |
制造用于缓释药物递送的治疗装置的方法
|
|
EP3439591B1
(en)
|
2016-04-05 |
2020-09-23 |
ForSight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
CA3022830A1
(en)
|
2016-04-20 |
2017-10-26 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
|
US11045309B2
(en)
|
2016-05-05 |
2021-06-29 |
The Regents Of The University Of Colorado |
Intraocular lens designs for improved stability
|
|
AU2017291707A1
(en)
|
2016-07-05 |
2019-01-03 |
Janssen Biotech, Inc. |
Treatment of retinal vascular disease using progenitor cells
|
|
IL270575B2
(en)
|
2017-06-13 |
2024-07-01 |
Eyepoint Pharmaceuticals Inc |
Biodegradable devices for drug delivery
|
|
US11382736B2
(en)
|
2017-06-27 |
2022-07-12 |
Alcon Inc. |
Injector, intraocular lens system, and related methods
|
|
US11103460B2
(en)
|
2017-08-07 |
2021-08-31 |
Board Of Regents, The University Of Texas System |
Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
|
|
JP7314155B2
(ja)
|
2017-11-21 |
2023-07-25 |
フォーサイト・ビジョン４・インコーポレーテッド |
膨張可能ポート送達システムのための流体交換装置及びその使用方法
|
|
WO2019226516A1
(en)
|
2018-05-24 |
2019-11-28 |
Celanese EVA Performance Polymers Corporation |
Implantable device for sustained release of a macromolecular drug compound
|
|
MX2020012459A
(es)
|
2018-05-24 |
2021-04-28 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
|
|
EP3803866A4
(en)
|
2018-05-24 |
2022-03-16 |
Nureva Inc. |
METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
|
|
US11779739B2
(en)
*
|
2018-12-21 |
2023-10-10 |
Perfect Ip, Llc |
Drug delivery system and method
|
|
CN113710805A
(zh)
|
2019-03-04 |
2021-11-26 |
杜克大学 |
用于诊断和治疗视网膜病变的组合物和方法
|
|
DK3861985T3
(da)
|
2020-02-06 |
2023-07-24 |
Ocular Therapeutix Inc |
Sammensætninger og fremgangsmåder til behandling af øjensygdomme
|
|
CA3169482A1
(en)
|
2020-02-26 |
2021-09-02 |
Krzysztof Palczewski |
Compositions and methods for treating misfolded protein ocular disorders
|
|
PT3884929T
(pt)
|
2020-03-25 |
2023-08-09 |
Ocular Therapeutix Inc |
Implante ocular contendo um inibidor da tirosina cinase
|
|
EP4142664A4
(en)
|
2020-04-27 |
2024-05-29 |
Ocular Therapeutix, Inc. |
METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS
|
|
KR102893953B1
(ko)
|
2020-09-24 |
2025-12-02 |
오큘라 테라퓨틱스, 인코포레이티드 |
하이드로겔 및 사이클로스포린을 포함하는 지속 방출 생분해성 소관내 삽입체
|
|
JP2023542939A
(ja)
|
2020-09-24 |
2023-10-12 |
オキュラ セラピューティクス，インコーポレイテッド |
ヒドロゲル及び活性薬剤を含む徐放性生分解性小管内挿入物
|
|
EP4329734A4
(en)
|
2021-04-26 |
2025-04-02 |
Celanese EVA Performance Polymers LLC |
Implantable device for the delayed release of a macromolecular drug compound
|
|
US11357620B1
(en)
|
2021-09-10 |
2022-06-14 |
California LASIK & Eye, Inc. |
Exchangeable optics and therapeutics
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
IL322360A
(en)
|
2023-04-11 |
2025-09-01 |
Ocular Therapeutix Inc |
Intraocular implant containing axitinib iv polymorph
|